These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1902503)

  • 21. Cell components required for deletion of an autoreactive T cell repertoire.
    Fukushi N; Wang BY; Arase H; Ogasawara K; Good RA; Onoé K
    Eur J Immunol; 1990 May; 20(5):1153-60. PubMed ID: 2113476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
    Fry AM; Cotterman MM; Matis LA
    J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice.
    Yui K; Komori S; Katsumata M; Siegel RM; Greene MI
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7135-9. PubMed ID: 2402496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
    Gaugler B; Langlet C; Martin JM; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1991 Oct; 21(10):2581-9. PubMed ID: 1680703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.
    Larsson-Sciard EL; Spetz-Hagberg AL; Casrouge A; Kourilsky P
    Eur J Immunol; 1990 Jun; 20(6):1223-9. PubMed ID: 2142455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal tolerance to MIs-1a determinants: deletion or anergy of V beta 6+ T lymphocytes depending upon MHC compatibility of neonatally injected cells.
    Speiser DE; Brändle R; Lees RK; Schneider R; Zinkernagel RM; MacDonald HR
    Int Immunol; 1991 Feb; 3(2):127-34. PubMed ID: 1709047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T cell response to Mls-1a determinants involves major histocompatibility complex class II molecules.
    Chvatchko Y; MacDonald HR
    J Exp Med; 1991 Mar; 173(3):779-82. PubMed ID: 1825506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 expression is differentially required for deletion of MLS-1a-reactive T cells.
    Wallace VA; Rahemtulla A; Timms E; Penninger J; Mak TW
    J Exp Med; 1992 Nov; 176(5):1459-63. PubMed ID: 1402689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
    J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.
    Rammensee HG; Kroschewski R; Frangoulis B
    Nature; 1989 Jun; 339(6225):541-4. PubMed ID: 2525232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of specificity for antigen, Mls, and allogenic MHC by transfer of T-cell receptor alpha- and beta-chain genes.
    Kaye J; Hedrick SM
    Nature; 1988 Dec; 336(6199):580-3. PubMed ID: 2849059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.
    Choi YW; Herman A; DiGiusto D; Wade T; Marrack P; Kappler J
    Nature; 1990 Aug; 346(6283):471-3. PubMed ID: 2377208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of neonatal tolerance to the Mls-1a self-super-antigen. Time kinetics and MHC restriction.
    Dannecker G; Mecheri S; Hoffmann MK
    J Immunol; 1991 Nov; 147(9):2833-8. PubMed ID: 1833458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.
    Gascoigne NR; Ames KT
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):613-6. PubMed ID: 1824876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.
    Kappler JW; Staerz U; White J; Marrack PC
    Nature; 1988 Mar; 332(6159):35-40. PubMed ID: 3126396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens.
    MacDonald HR; Schneider R; Lees RK; Howe RC; Acha-Orbea H; Festenstein H; Zinkernagel RM; Hengartner H
    Nature; 1988 Mar; 332(6159):40-5. PubMed ID: 3126397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a).
    Winslow GM; Scherer MT; Kappler JW; Marrack P
    Cell; 1992 Nov; 71(5):719-30. PubMed ID: 1330323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.